Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Stopped The study is no longer moving forward due to the changing TB vaccine landscape.

Conditions

• Tuberculosis
• HIV Infections

Interventions

• BIOLOGICAL: VPM1002 Vaccine
• BIOLOGICAL: BCG Vaccine
• DRUG: Placebo

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Collaborators

• [object Object]
• [object Object]
• [object Object]